SCHEMBL488855

SCHEMBL488855

CCN(CC)Cc1c[nH]c2ccc(-c3ccnc(N)c3OCc3c(Cl)cccc3Cl)cc12

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MPO P05164 1/20 0.41
MEN1 O00255 2/20 0.39
ALDH1A1 P00352 2/20 0.39
KMT2A Q03164 2/20 0.39
KDM4E B2RXH2 1/20 0.39
MAPT P10636 1/20 0.39
HPGD P15428 1/20 0.39
HSD17B10 Q99714 1/20 0.39
PIM1 P11309 8/20 0.37
PIM3 Q86V86 7/20 0.36
PIM2 Q9P1W9 7/20 0.36
HTR1D P28221 2/20 0.35
ICMT O60725 2/20 0.35
HTR6 P50406 1/20 0.34
MET P08581 1/20 0.34
USP2 O75604 1/20 0.33
LMNA P02545 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2D6 P10635 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL488881 0.82 S1PR1 (0.41) KDM4EHTR1DMETLMNACYP2D6
SCHEMBL487672 0.81 MET (0.54) MPOMEN1ALDH1A1KMT2AKDM4E
SCHEMBL488865 0.81 LMNA (0.41) ALDH1A1KDM4EHTR1DMETLMNA
SCHEMBL27630059 0.76 ICMT (0.41) MPOMEN1ALDH1A1KMT2AKDM4E
SCHEMBL488857 0.72 MPO (0.43) MPOMEN1ALDH1A1KMT2AKDM4E
SCHEMBL488920 0.68 MPO (0.44) MPOMEN1ALDH1A1KMT2AKDM4E
SCHEMBL30452546 0.68 MPO (0.44) MPOMEN1ALDH1A1KMT2AKDM4E
SCHEMBL21724167 0.66 MPO (0.68) MPOMEN1ALDH1A1KMT2AKDM4E
SCHEMBL27650232 0.63 MPO (0.44) MPOMEN1ALDH1A1KMT2AKDM4E
SCHEMBL488007 0.63 MET (0.53) KDM4EHTR1DMETLMNAMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8106197-B2 Aminoheteroaryl compounds as protein kinase inhibitors PFIZER INC. (US) 2012-01-31 US disclosed
US-20070072874-A1 Aminoheteroaryl compounds as protein kinase inhibitors SUGEN, INC. 2007-03-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070072874-A1 Aminoheteroaryl compounds as protein kinase inhibitors MET, MAP4K1, MAP4K2 MPO 4689/4885MEN1 1141/4885ALDH1A1 2031/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.